The clinical effect of catecholamine-blocking drugs (alpha-methyldopa, propanolol) in patients with hyperkinetic disorders.
D004569:Electroencephalography; D004576:Electromyography; D006801:Humans; D008750:Methyldopa / Q000627:therapeutic use*; D009069:Movement Disorders / Q000188:drug therapy*; D011433:Propranolol / Q000627:therapeutic use*
D008750:Methyldopa; D011433:Propranolol